![]() Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs. | ![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. | |
Founding Date | Founding Date 1986 | Founding Date 1993 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Colmenar Viejo, ES HQ Madrid, ES | Locations San Diego, US HQ | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US |
Employees | Employees 500 | Employees 878% decrease | Employees 8154% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) 2.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) €221.4m (FY, 2025) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $517.1m (FY, 2025) |
Cost of goods | Cost of goods €12.3m (FY, 2025) | Cost of goods $28.4m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit €232m (FY, 2025) | Gross profit ($2.5m) (FY, 2022) | Gross profit $362.5m (FY, 2025) |
Net income | Net income €75m (FY, 2025) | Net income ($32.1m) (FY, 2022) | Net income $66.4m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 15.9m | Total funding raised $ 116.3m |

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View companyVeracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View company